Development of an Ion-Pair Reverse-Phase Liquid Chromatographic/Tandem Mass Spectrometry Method for the Determination of an 18-Mer Phosphorothioate Oligonucleotide in Mouse Liver Tissue
- 1 April 2005
- journal article
- research article
- Published by SAGE Publications in European Journal of Mass Spectrometry
- Vol. 11 (2) , 209-215
- https://doi.org/10.1255/ejms.674
Abstract
A quantitative method for the determination of a partially modified, 2′-ribose alkoxy 18-mer phosphorothioate oligonucleotide in liver tissue has been developed. A liquid:liquid extraction, ion-pair reverse phase chromatographic separation and tandem mass spectrometry were used to achieve a quantitation range of 125 to 10,000 ng g−1 mouse liver tissue. A total cycle time of 5 min was obtained while maintaining separation of three potential impurities. Separations were performed using a Discovery RP-Amide C16, 100 × 2 mm column packed with 5 μm particles. The separation was facilitated by the use of triethylamine (TEA) and hexafluoroisopropanol (HFIP) as ion-pair agents. The method has subsequently been used for the determination of other phosphorothioate oligonucleotides in support of discovery research.Keywords
This publication has 20 references indexed in Scilit:
- Antisense therapy for cancer—the time of truthThe Lancet Oncology, 2002
- Antisense therapeutics: lessons from early clinical trialsCurrent Opinion in Oncology, 2001
- A Phase I trial of h-ras antisense oligonucleotide ISIS 2503 administered as a continuous intravenous infusion in patients with advanced carcinomaCancer, 2001
- Potential roles of antisense technology in cancer chemotherapyOncogene, 2000
- Phosphorothioate Oligodeoxynucleotides: What Is Their Origin and What Is Unique About Them?Antisense and Nucleic Acid Drug Development, 2000
- Antisense Approaches for the Treatment of CancerCancer Investigation, 2000
- Quantitation of Phosphorothioate Oligonucleotides in Human Blood Plasma Using a Nanoparticle-Based Method for Solid-Phase ExtractionAnalytical Chemistry, 1998
- An Overview of Progress in Antisense TherapeuticsAntisense and Nucleic Acid Drug Development, 1998
- Quantitation of Phosphorothioate Oligonucleotides in Human PlasmaAnalytical Biochemistry, 1996
- High-performance liquid chromatographic analysis of phosphorothioate analogues of oligodeoxynucleotides in biological fluidsJournal of Chromatography B: Biomedical Sciences and Applications, 1990